project: cardiodx

CardioDX logo

Connect with a Sales Specialist


CardioDx Board of Directors

Ajit Singh, Ph.D. | Managing Director, Artiman Management, LLC

Dr. Singh has served as a member of our board of directors since April 2012. Since January 2011, Dr. Singh has been a managing director of Artiman Management, L.L.C., a venture capital firm, where he focuses on investing in early-stage technology, life sciences and medical technology companies. Prior to joining Artiman, he was the President and Chief Executive Officer of BioImagene, Inc., a digital pathology company, from October 2008 until BioImagene was acquired by Ventana Medical Systems, Inc., a member of the Roche Group, in September 2010. Dr. Singh also serves on the boards of several privately-held companies and Max India Ltd, which is listed on stock exchanges in India. Dr. Singh is also a Consulting Professor in the School of Medicine at Stanford University. Dr. Singh holds a Ph.D. in Computer Science from Columbia University, an M.S. in Computer Engineering from Syracuse University and a B.S. in Electrical Engineering from Banaras Hindu University, India. 

Hongjie Hu | Director, Investments, Temasek

Patrick G. Enright | Managing Director, Longitude Capital

Mr. Enright has served as a member of our board of directors since February 2011. Since 2006, Mr. Enright has served as a Managing Director of Longitude Capital, a venture capital firm, of which he is a founder. From 2002 through 2006, Mr. Enright was a Managing Director of Pequot Ventures, a venture capital firm, where he co-led the life sciences investment practice. Mr. Enright also has significant life sciences operations experience, beginning his career more than 25 years ago at Sandoz (now Novartis AG). He currently serves on the boards of directors of Jazz Pharmaceuticals plc, Corcept Therapeutics Incorporated, Esperion Therapeutics, Inc., and several privately-held companies. In the past five years he also served as a director of Threshold Pharmaceuticals, Inc. and Sequenom, Inc. Mr. Enright received an M.B.A. from the Wharton School at the University of Pennsylvania and a B.S. in Biological Sciences from Stanford University. 

Khush F. Mehta | President and CEO, CardioDx

David Levison | Chief Strategy Officer, CardioDx